Frank Gilberg

3.5k citations
44 papers · 2.4k · 2 hit papers · h-index 18

Impact in

  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
    • Cancer Treatment and Pharmacology
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Gastric Cancer Management and Outcomes

Papers in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 23
    • Pulmonary Hypertension Research and Treatments 3
    • Respiratory and Cough-Related Research 3
    • Colorectal Cancer Treatments and Studies 10
    • Cancer Treatment and Pharmacology 5

Frank Gilberg

43 papers receiving 2.3k citations

Frank Gilberg's Hit Papers

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial 2019 · 411 citations
4110+5+10Years since publication100200300400500

Peers

Frank Gilberg
Comparison fields: 5 of 88
  • Oncology 968
  • Pulmonary and Respiratory Medicine 902
  • Pathology and Forensic Medicine 300
  • Hepatology 72
  • Dermatology 83
Replace William J. Edenfield with:
William J. Edenfield United States
Süleyman Buyukberber Türkiye
Hyunseok Kang United States
Erich M. Sturgis United States
Rita Lionetto Italy
Keiichiro Ishibashi Japan
J. Philip Kuebler United States
Wen-Qi Jiang China
Enrico Aitini Italy
Claus Rödel Germany
Frank Gilberg relative to William J. Edenfield United States William J. Edenfield's profile →
Citations per field
00.5×7.2×
William J. Edenfield · 1×
Citations per year

Countries citing papers authored by Frank Gilberg

Since Specialization
Citations

This map shows the geographic impact of Frank Gilberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Gilberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Gilberg more than expected).

Fields of papers citing papers by Frank Gilberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Gilberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Gilberg. The network helps show where Frank Gilberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Frank Gilberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Gilberg Line = papers co-authored together Frank Gilberg links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
Hit paper breakdown →
2011552
2
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
2019411
3 2008188
4 2011182
5 2017145
6 2011127
7 2002105
8 2018104
9 2020100
10 201877
11 201175
12 201838
13 201038
14 202233
15 201029
16 201827
17 200925
18 202217
19 201816
20 201215

About Frank Gilberg

Frank Gilberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Dermatology and Physiology, having authored 44 papers that have together received 2.4k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (5 papers), Pulmonary Hypertension Research and Treatments (3 papers), Hedgehog Signaling Pathway Studies (3 papers), Respiratory and Cough-Related Research (3 papers), Cancer and Skin Lesions (2 papers) and Sarcoidosis and Beryllium Toxicity Research (2 papers). The work is most often cited by research in Oncology (968 citations), Pulmonary and Respiratory Medicine (902 citations), Pathology and Forensic Medicine (300 citations), Hepatology (72 citations) and Dermatology (83 citations). Frank Gilberg has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Eric Van Cutsem, Hans‐Joachim Schmoll, Josep Tabernero, Karen Rittweger, Daniel G. Haller, Filippo de Braud, Jean A. Maroun, Klaus-Uwe Kirchgaessler, Timothy Price and Mark Hill. Their work appears in journals such as Journal of Clinical Oncology, Advances in Therapy, Annals of Oncology, CHEST Journal and The Lancet Respiratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact